US halts hydroxychloroquine clinical trial after finding no additional benefit for Covid-19 patients (cnn.com)
The National Institutes of Health announced Saturday that it has halted a clinical trial evaluating the safety and effectiveness of drug hydroxychloroquine as a treatment for adults hospitalized with Covid-19.
"A data and safety monitoring board met late Friday and determined that while there was no harm, the study drug was very unlikely to be beneficial to hospitalized patients with Covid-19," the NIH said in a statement.
- Log in to post comments
